C Huang1, D Jiang1, D Francisco2, R Berman1, Q Wu1, J G Ledford2, C M Moore1, Y Ito1, C Stevenson1, D Munson1, L Li3, M Kraft2, H W Chu1. 1. Department of Medicine, National Jewish Health, Denver, CO, USA. 2. Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA. 3. Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Abstract
BACKGROUND: Rhinovirus (RV) infection in asthma induces varying degrees of airway inflammation (e.g. neutrophils), but the underlying mechanisms remain unclear. OBJECTIVE: The major goal was to determine the role of genetic variation [e.g. single nucleotide polymorphisms (SNPs)] of Toll-interacting protein (Tollip) in airway epithelial responses to RV in a type 2 cytokine milieu. METHODS: DNA from blood of asthmatic and normal subjects was genotyped for Tollip SNP rs5743899 AA, AG and GG genotypes. Human tracheobronchial epithelial (HTBE) cells from donors without lung disease were cultured to determine pro-inflammatory and antiviral responses to IL-13 and RV16. Tollip knockout and wild-type mice were challenged with house dust mite (HDM) and infected with RV1B to determine lung inflammation and antiviral response. RESULTS: Asthmatic subjects carrying the AG or GG genotype (AG/GG) compared with the AA genotype demonstrated greater airflow limitation. HTBE cells with AG/GG expressed less Tollip. Upon IL-13 and RV16 treatment, cells with AG/GG (vs. AA) produced more IL-8 and expressed less antiviral genes, which was coupled with increased NF-κB activity and decreased expression of LC3, a hallmark of the autophagic pathway. Tollip co-localized and interacted with LC3. Inhibition of autophagy decreased antiviral genes in IL-13- and RV16-treated cells. Upon HDM and RV1B, Tollip knockout (vs. wild-type) mice demonstrated higher levels of lung neutrophilic inflammation and viral load, but lower levels of antiviral gene expression. CONCLUSIONS AND CLINICAL RELEVANCE: Our data suggest that Tollip SNP rs5743899 may predict varying airway response to RV infection in asthma.
BACKGROUND: Rhinovirus (RV) infection in asthma induces varying degrees of airway inflammation (e.g. neutrophils), but the underlying mechanisms remain unclear. OBJECTIVE: The major goal was to determine the role of genetic variation [e.g. single nucleotide polymorphisms (SNPs)] of Toll-interacting protein (Tollip) in airway epithelial responses to RV in a type 2 cytokine milieu. METHODS: DNA from blood of asthmatic and normal subjects was genotyped for Tollip SNP rs5743899 AA, AG and GG genotypes. Human tracheobronchial epithelial (HTBE) cells from donors without lung disease were cultured to determine pro-inflammatory and antiviral responses to IL-13 and RV16. Tollip knockout and wild-type mice were challenged with house dust mite (HDM) and infected with RV1B to determine lung inflammation and antiviral response. RESULTS: Asthmatic subjects carrying the AG or GG genotype (AG/GG) compared with the AA genotype demonstrated greater airflow limitation. HTBE cells with AG/GG expressed less Tollip. Upon IL-13 and RV16 treatment, cells with AG/GG (vs. AA) produced more IL-8 and expressed less antiviral genes, which was coupled with increased NF-κB activity and decreased expression of LC3, a hallmark of the autophagic pathway. Tollip co-localized and interacted with LC3. Inhibition of autophagy decreased antiviral genes in IL-13- and RV16-treated cells. Upon HDM and RV1B, Tollip knockout (vs. wild-type) mice demonstrated higher levels of lung neutrophilic inflammation and viral load, but lower levels of antiviral gene expression. CONCLUSIONS AND CLINICAL RELEVANCE: Our data suggest that Tollip SNP rs5743899 may predict varying airway response to RV infection in asthma.
Authors: K Burns; J Clatworthy; L Martin; F Martinon; C Plumpton; B Maschera; A Lewis; K Ray; J Tschopp; F Volpe Journal: Nat Cell Biol Date: 2000-06 Impact factor: 28.824
Authors: Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: Matthew L Mayer; Christoph J Blohmke; Reza Falsafi; Chris D Fjell; Laurence Madera; Stuart E Turvey; Robert E W Hancock Journal: J Immunol Date: 2012-12-21 Impact factor: 5.422
Authors: Qun Wu; Linda F van Dyk; Di Jiang; Azzeddine Dakhama; Liwu Li; Steven R White; Ashley Gross; Hong Wei Chu Journal: Virology Date: 2013-08-30 Impact factor: 3.616
Authors: John M Coleman; Chetan Naik; Fernando Holguin; Anuradha Ray; Prabir Ray; John B Trudeau; Sally E Wenzel Journal: Thorax Date: 2012-09-26 Impact factor: 9.139
Authors: Hong Wei Chu; Joyce M Honour; Catherine A Rawlinson; Ronald J Harbeck; Richard J Martin Journal: Infect Immun Date: 2003-03 Impact factor: 3.441
Authors: Ana Filipa Rodrigues; Ana Mafalda Santos; Ana Maria Ferreira; Roberta Marino; Maria Esmeralda Barreira; José Manuel Cabeda Journal: Food Environ Virol Date: 2019-07-26 Impact factor: 2.778